Zacks.com highlights: Covanta Holding, AMC Entertainment Holdings, Incyte, PTC and Cott

For Immediate Release

Chicago, IL – Jan 03, 2018 - Stocks in this week’s article include: Covanta Holding Corporation CVA, AMC Entertainment Holdings, Inc. AMC, Incyte Corporation INCY, PTC Inc. PTC and Cott Corporation COT.

Screen of the Week of Zacks Investment Research:

Abandon These 5 Toxic Stocks or Sell Short for Profit

One important criterion for successful investing is accurate identification of overblown toxic stocks and the rightly priced ones. However, it is not easy to precisely distinguish these two categories of stocks. Investors who can figure out the toxic stocks correctly and throw them away at the right time are likely to gain at the end.  

Overhyped toxic stocks are usually vulnerable to outside shocks and burdened with a huge amount of debt. Also, the price of toxic stocks is unreasonably inflated. However, the high price of the toxic stocks is only temporary as  it is higher than its intrinsic value.

The unjustifiably high price of toxic stocks can be ascribed to either an irrational exuberance associated with them or some serious fundamental drawbacks associated with the stock. Owning such bloated stocks for an inordinate period of time can be corrosive to investors and may result in huge loss of wealth.

Investors may benefit from the correct identification of toxic stocks with the help of an investing strategy known as short selling. This strategy allows them to sell a stock first and then buy it when the price falls.

While short selling excels in bear markets, it typically loses money in bull markets.

So, identifying toxic stocks and abandoning them at the accurate time is the key to protect your portfolio from big losses. Profits can be made by short selling them.

And that's what we're screening for today…

For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/287441/abandon-these-5-toxic-stocks-or-sell-short-for-profit

Get the remaining stocks on the list and start putting this and other ideas to the test. It can all be done with the Research Wizard stock picking and back testing software.

The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.

Click here to sign up for a free trial to the Research Wizard today.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week

Zacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:  https://twitter.com/zacksresearch

Join us on Facebook:  https://www.facebook.com/ZacksInvestmentResearch

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto

Company: Zacks.com

Phone: 312-265-9268

Email: pr@zacks.com

Visit: https://www.zacks.com/

Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cott Corporation (COT) : Free Stock Analysis Report
 
PTC Inc. (PTC) : Free Stock Analysis Report
 
AMC Entertainment Holdings, Inc. (AMC) : Free Stock Analysis Report
 
Incyte Corporation (INCY) : Free Stock Analysis Report
 
Covanta Holding Corporation (CVA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.